Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design
Christopher W. Fleming et al.
ORAL ONCOLOGY (2021)
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
Kate Clancy et al.
CANCERS (2021)
Active HPV infection and its influence on survival in head and neck squamous-cell cancer
Anna Janecka-Widla et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol
Anthony Kong et al.
BMJ OPEN (2020)
Management of HPV-Related Squamous Cell Carcinoma of the Head and Neck: Pitfalls and Caveat
Francesco Perri et al.
CANCERS (2020)
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
Apostolos Klinakis et al.
EBIOMEDICINE (2020)
Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer
Angela M. Hong et al.
ORAL ONCOLOGY (2019)
Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+tumor-infiltrating lymphocytes
Xiao-Jie Chen et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
Francesca Finotello et al.
GENOME MEDICINE (2019)
HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma
Jian Wang et al.
SCIENTIFIC REPORTS (2019)
Comprehensive Genomic Review of TCGA Head and Neck Squamous Cell Carcinomas (HNSCC)
Mario Perez Sayans et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Ranee Mehra et al.
BRITISH JOURNAL OF CANCER (2018)
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas
Alexis Desrichard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Robert L. Ferris et al.
ORAL ONCOLOGY (2018)
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas
Alexis Desrichard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients
Ari Vanderwalde et al.
CANCER MEDICINE (2018)
Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014
Amanda-Louise Fenger Carlander et al.
EUROPEAN JOURNAL OF CANCER (2017)
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing
Takafumi Nakagaki et al.
ONCOTARGET (2017)
Emerging Insights Into Recurrent and Metastatic Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma
Farhoud Faraji et al.
LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY (2017)
Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures
Yanxiao Zhang et al.
CLINICAL CANCER RESEARCH (2016)
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
I. Tinhofer et al.
EUROPEAN JOURNAL OF CANCER (2016)
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
Ge Zhou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Further evaluations of nivolumab (nivo) versus investigator's choice (IC) chemotherapy for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CheckMate 141.
Robert L. Ferris et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma
Maura L. Gillison et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Trends in head and neck cancers in England from 1995 to 2011 and projections up to 2025
Karly S. Louie et al.
ORAL ONCOLOGY (2015)
p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma
Carole Fakhry et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
The role of HPV in head and neck cancer and review of the HPV vaccine
Gypsyamber D'Souza et al.
PREVENTIVE MEDICINE (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
p16 Positive Oropharyngeal Squamous Cell Carcinoma: An Entity With a Favorable Prognosis Regardless of Tumor HPV Status
James S. Lewis et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Comparative Prognostic Value of HPV16 E6 mRNA Compared With In Situ Hybridization for Human Oropharyngeal Squamous Carcinoma
Wei Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
ML Gillison et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
